Semantic Scholar uses AI to extract papers important to this topic.
The UK-based National Institute for Health and Care Excellence (NICE) has updated its guidance on iron deficiency and anemia… Expand BACKGROUND
In haemodialysis (HD) patients, anaemia is associated with reduced survival. Despite treatment with erythropoiesis… Expand BACKGROUND
Peginesatide is a peptide-based erythropoiesis-stimulating agent (ESA) that may have therapeutic potential for anemia… Expand The KDIGO (Kidney Disease: Improving Global Outcomes) 2012 clinical practice guideline for anemia management in patients with… Expand BACKGROUND
Peginesatide, a synthetic peptide-based erythropoiesis-stimulating agent (ESA), is a potential therapy for anemia in… Expand BACKGROUND
The anaemia seen in chronic kidney disease (CKD) may be exacerbated by iron deficiency. Iron can be provided through… Expand Background. Intravenous (i.v.) iron sucrose similar (ISS) preparations are available but clinical comparisons with the originator… Expand BACKGROUND
Shortening of red blood cell (RBC) survival contributes to the anemia of chronic kidney disease. The toxic uremic… Expand Randomized trials have endeavored to show that using ESAs to raise hemoglobin concentrations to higher targets improves clinical… Expand Patients with myelodysplastic syndromes (MDS) often develop anaemia resulting in frequent transfusions and fatigue. Darbepoetin… Expand